FDA has cleared a family of cervical and lumbar interbody fusion devices manufactured with Amedica’s silicon nitride biomaterial. Features of the product portfolio include a threaded insertion feature, additional footprints and design elements intended to allow surgeons to perform minimally invasive and lumbar lateral interbody fusion approaches, according to the company.
“Amedica is now better positioned to deliver a technology that can change the standard of care for spinal surgery,” said Eric K. Olson, president and CEO of Amedica, in the release. “The enhancements we have made to our interbody line of products including the LLIF devices speak to our long term commitment to improve interbody fusion procedures by providing a premium product that enhances the surgeon experience while dramatically improving patient outcomes.”
Amedica Corp. is headquartered in Salt Lake City.
Related Articles on FDA Clearances:
Dallen Medical Files for FDA Clearance for Compressyn Staple
Merit Medical Receives FDA Clearance for Hydrophilic Guide Wire
Smiths Medical Receives FDA Clearance for Portex CorrectInject Safety System
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
